A Prospective, Cross-Sectional Study Exploring the Relationship Between Neurosteroids Hormones and Women’s Dysmenorrhea

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400079587

Enrollment

Unknown

Registered

2024-01-08

Start date

2022-10-01

Completion date

Unknown

Last updated

2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dysmenorrhea

Interventions

none:Blood mass spectrometry examination

Eligibility

Sex/Gender

Female

Age

18 Years to 49 Years

Inclusion criteria

Inclusion criteria: ? Women of childbearing age (definition: women of childbearing potential at the age of 15 to 49) ? The estimated date of blood collection is 3-10 days from the date of the last menstrual period ? Agree to sign the informed consent form

Exclusion criteria

Exclusion criteria: ? Pregnancy status ? Patients receiving any hormonal therapy (including oral contraceptives, and other hormones that affect neurosteroids levels of drugs such as glucocorticoids, opioid analgesics, and selective serotonin reuptake inhibitors, etc.) ? Diagnosed with polycystic ovary syndrome ? Abnormal liver and kidney function ? Combined with neurological diseases ? Failure to complete follow-up visits or sign informed consent for various reasons

Design outcomes

Primary

Measure	Time frame
Pregnenolone;	—

Secondary

Measure	Time frame
17a-Hydroxypregnenolone;17-a-hydoxy-progesterone;	—

Countries

China

Contacts

Public ContactJiarong Zhang

Zhongshan Hospital of Fudan University

zhang.jiarong@zs-hospital.sh.cn+86 158 0045 1157

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 26, 2026